(Q83967473)
Statements
Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine (English)
Mizue Terai
David Berd
Inna Chervoneva
Kashyap Patel
Michael J Mastrangelo